Downregulation of ATM and BRCA1 Predicts Poor Outcome in Head and Neck Cancer: Implications for ATM-Targeted Therapy.

Wang, Yu-Chu; Lee, Ka-Wo; Tsai, Yi-Shan; Lu, Hsing-Han; Chen, Si-Yun; Hsieh, Hsin-Ying; Lin, Chang-Shen

Wang, Yu-Chu; Lee, Ka-Wo; Tsai, Yi-Shan; Lu, Hsing-Han; Chen, Si-Yun; Hsieh, Hsin-Ying; Lin, Chang-Shen.

Afiliação

Wang YC; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Lee KW; Department of Otorhinolaryngology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan.
Tsai YS; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Lu HH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chen SY; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Hsieh HY; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Lin CS; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

J Pers Med ; 11(5)2021 May 10.

Article em En | MEDLINE | ID: mdl-34068585

Palavras-chave

ATM; BRCA1; KU55933; betel quid; biomarker; head and neck cancer; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google